Hepato-cardiac disorders
Yasser Mahrous Fouad1, Reem Yehia1
1Yasser Mahrous Fouad, Reem Yehia, Gastroenterology and Hepatology Unit, Endemic Medicine Department, Minia University, Minia 19111, Egypt.
Insights
This review explores hepato-cardiac diseases, where heart conditions impact the liver and vice-versa. Understanding this connection is crucial for diagnosing and managing conditions affecting both organs.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- The interplay between liver and heart health is clinically significant for specialists in both fields.
- Hepato-cardiac diseases encompass conditions where the heart affects the liver, the liver affects the heart, or both organs are simultaneously impacted.
- Accurate diagnosis of liver injury is vital in cardiology, necessitating collaboration to differentiate from conditions mimicking hemodynamic compromise.
Purpose of the Study:
- To review the spectrum of hepato-cardiac diseases.
- To highlight the diagnostic challenges and collaborative needs between cardiologists and hepatologists.
- To discuss the impact of cardiac conditions on the liver and vice versa, including systemic diseases affecting both.
Main Methods:
- Literature review of hepato-cardiac diseases.
- Classification of conditions based on organ involvement (heart-to-liver, liver-to-heart, simultaneous).
- Discussion of clinical implications, diagnostic considerations, and management strategies.
Main Results:
- Heart failure can cause ischemic hepatitis or congestive hepatopathy, requiring management of the primary cardiac issue.
- Advanced liver disease may lead to cirrhotic cardiomyopathy, characterized by hemodynamic and functional cardiac alterations.
- Liver transplantation can reverse cardiac dysfunction in patients with end-stage liver disease.
Conclusions:
- Effective management of hepato-cardiac conditions requires a multidisciplinary approach.
- Cardiac evaluation is essential for patients with liver disease, particularly around liver transplantation.
- Systemic diseases, including congenital, metabolic, inflammatory conditions, and alcoholism, represent significant etiological factors for concurrent heart and liver disease.
Abstract:
Understanding the mutual relationship between the liver and the heart is important for both hepatologists and cardiologists. Hepato-cardiac diseases can be classified into heart diseases affecting the liver, liver diseases affecting the heart, and conditions affecting the heart and the liver at the same time. Differential diagnoses of liver injury are extremely important in a cardiologist's clinical practice calling for collaboration between cardiologists and hepatologists due to the many other diseases that can affect the liver and mimic haemodynamic injury. Acute and chronic heart failure may lead to acute ischemic hepatitis or chronic congestive hepatopathy. Treatment in these cases should be directed to the primary heart disease. In patients with advanced liver disease, cirrhotic cardiomyopathy may develop including hemodynamic changes, diastolic and systolic dysfunctions, reduced cardiac performance and electrophysiological abnormalities. Cardiac evaluation is important for patients with liver diseases especially before and after liver transplantation. Liver transplantation may lead to the improvement of all cardiac changes and the reversal of cirrhotic cardiomyopathy. There are systemic diseases that may affect both the liver and the heart concomitantly including congenital, metabolic and inflammatory diseases as well as alcoholism. This review highlights these hepatocardiac diseases.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Portal Hypertension
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care


